{
  "ef_id": "f3d409bb-5b6a-4101-81a5-e9add823c323",
  "enrichment_payload": {
    "canonical_actors": [
      {
        "name": "EU",
        "role": "initiator"
      },
      {
        "name": "Daiichi Sankyo",
        "role": "beneficiary"
      },
      {
        "name": "AstraZeneca",
        "role": "beneficiary"
      }
    ],
    "policy_status": "validated",
    "time_span": {
      "start": "2025-09-11",
      "end": null
    },
    "magnitude": [],
    "official_sources": [],
    "why_strategic": "EU regulatory validation strengthens European biotech security, accelerates precision oncology innovation, and enhances patient access to advanced can"
  },
  "enriched_at": "2025-09-19 20:47:47.715196",
  "enrichment_version": "v1.0",
  "sources_found": 0,
  "tokens_used": 0,
  "processing_time_ms": 8969,
  "status": "completed",
  "error_message": null
}